Clinical Assessment of a Motorized Spinal Distraction Rod in the Severe to Early Scoliosis Child
- Conditions
- Scoliosis
- Interventions
- Device: ASTS
- Registration Number
- NCT03330158
- Lead Sponsor
- University Hospital, Toulouse
- Brief Summary
The purpose of this biomedical research is to evaluate the feasibility of the treatment with the new spinal distraction device ASTS in patients aged 4 to 10 years with severe early onset scoliosis.
The hypothesis of this project is that the new fully implantable motorized spinal distraction device may provide a correction of scoliosis and progressive elongation ensuring patient comfort and minimizing complications.
The ASTS (for Active Scoliosis Treatment System) growing rod is a new fully implantable motorized spinal distraction device which can ensure a correction of scoliosis and progressive elongation ensuring patient comfort and minimizing complications.
- Detailed Description
Despite a better understanding and technical progress, the evolutionary early scoliosis remains a therapeutic challenge. The definition includes idiopathic scoliosis beginning before the age of 3 years, congenital scoliosis, neuromuscular and syndromic. Spinal deformity is often progressive and may compromise cardiorespiratory function.
The goal of treatment is to prevent further avoiding spinal fusion in a subject in growth. Surgery is indicated in case of failure or cons-indication of conservative treatment (corset or plaster). The principle is to position the posterior rods subcutaneous or in muscle attached to two ends of the deformation.
Intraoperative distraction allows correction of the deformity. A new distraction is performed every 6 months until skeletal maturity.
Considerable complication rates are reported (58%), mainly implant infections and disassembly, because of the need for multiple reoperations. Motorized implants can potentially avoid repeated interventions limiting complications.
Thus, the central hypothesis of this project is a new fully implantable motorized spinal distraction device may provide a correction of scoliosis and progressive elongation ensuring patient comfort and minimizing complications.
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 5
- Patient 4 to 10 years
- Patient weight between 15kg at 50kg
- Introducing severe scoliosis (Cobb angle> 40 °) with early onset
- Failed or cons-indication of conservative treatment (cast or brace)
- Agreement of parents or legal guardian (written agreement) and the patient (at least an oral agreement).
- Contraindication to surgery
- Age less than 4 years or above 10 years
- Weight less 15kg and above 50 kg
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description ASTS device ASTS Implantation of device ASTS (for ACTIVE TREATMENT SCOLIOSIS SYSTEM ) in children between 4 and 10
- Primary Outcome Measures
Name Time Method Change of the implant's length 3 months, 6 months, 9 months, 1 year, 2 years and 3 years after the implantation The elongation of the implant will be measured in mm on the digital radiography
Change of the position of the implant 3 years after the implantation 3 years after the implantation of the device, radiographs will be realised to ensure that the implant is still weel positioning
Ability to Implant the device Day 0: the day of the implantation The surgeon will have to say if the implantation of the device has been done or not
- Secondary Outcome Measures
Name Time Method Determine the number of iterative extensions made during follow-up 1 year Number of iterative extensions of 1 year.
correction of deformation immediately after the operation, 3 months after implantation Number of participant with correction of deformation immediately after the operation,
Nature of complications 5 years describe the nature of complication
Post-surgical pain 1 year after the implantation Self-assessment of pain using a visual analog scale
wound closure without tension, Day 0 Number of participant with closure of the wound without tension,
Number of medical visits 1 year Measure of the number of medical visit in the year after implant
Effective Elongation measured on radiographs of specification of the device 1 year after implantation Effective Elongation measured on radiographs of specification of the device (in mm)
good positioning of the radiographic implant. Day 0 Number participant with good positioning of the radiographic implant.
Loss correction at 1 year 1 year after implantation Loss correction at 1 year
Effective Elongation measured on radiographs of specification of the device (in mm) 3 months after implantation Effective Elongation measured on radiographs of specification of the device (in mm)
Survey to evaluate the quality of life 1 year after the implantation Assess quality of life in the questionnaire PedsQL
to ease for the surgeon to implant the device, Day 0 Number of participant with ease for the surgeon to implant the device,
Increase the distance T1-S1 at 1 year 1 year Increase the distance T1-S1 at 1 year (in mm)
Trial Locations
- Locations (1)
CHU de Toulouse
🇫🇷Toulouse, France